134 related articles for article (PubMed ID: 2824549)
1. Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors.
Reubi JC; Häcki WH; Lamberts SW
J Clin Endocrinol Metab; 1987 Dec; 65(6):1127-34. PubMed ID: 2824549
[TBL] [Abstract][Full Text] [Related]
2. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of receptors for somatostatin in various tumors using different analogs.
Srkalovic G; Cai RZ; Schally AV
J Clin Endocrinol Metab; 1990 Mar; 70(3):661-9. PubMed ID: 1968467
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas.
Reubi JC; Waser B; Khosla S; Kvols L; Goellner JR; Krenning E; Lamberts S
J Clin Endocrinol Metab; 1992 May; 74(5):1082-9. PubMed ID: 1349024
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptors in human prostate and prostate cancer.
Reubi JC; Waser B; Schaer JC; Markwalder R
J Clin Endocrinol Metab; 1995 Sep; 80(9):2806-14. PubMed ID: 7673428
[TBL] [Abstract][Full Text] [Related]
6. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status.
Reubi JC; Landolt AM
J Clin Endocrinol Metab; 1989 Apr; 68(4):844-50. PubMed ID: 2537844
[TBL] [Abstract][Full Text] [Related]
7. Human kidney as target for somatostatin: high affinity receptors in tubules and vasa recta.
Reubi JC; Horisberger U; Studer UE; Waser B; Laissue JA
J Clin Endocrinol Metab; 1993 Nov; 77(5):1323-8. PubMed ID: 7915721
[TBL] [Abstract][Full Text] [Related]
8. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.
Lamberts SW; Hofland LJ; van Koetsveld PM; Reubi JC; Bruining HA; Bakker WH; Krenning EP
J Clin Endocrinol Metab; 1990 Sep; 71(3):566-74. PubMed ID: 2168430
[TBL] [Abstract][Full Text] [Related]
9. High density of somatostatin receptors in pituitary tumors from acromegalic patients.
Reubi JC; Landolt AM
J Clin Endocrinol Metab; 1984 Dec; 59(6):1148-51. PubMed ID: 6092412
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptors in differentiated ovarian tumors.
Reubi JC; Horisberger U; Klijn JG; Foekens JA
Am J Pathol; 1991 May; 138(5):1267-72. PubMed ID: 1850962
[TBL] [Abstract][Full Text] [Related]
11. Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses.
Reubi JC; Heitz PU; Landolt AM
J Clin Endocrinol Metab; 1987 Jul; 65(1):65-73. PubMed ID: 3034958
[TBL] [Abstract][Full Text] [Related]
12. In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090).
Faglia G; Bazzoni N; Spada A; Arosio M; Ambrosi B; Spinelli F; Sara R; Bonino C; Lunghi F
J Clin Endocrinol Metab; 1991 Oct; 73(4):850-6. PubMed ID: 1653785
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptors and somatostatin content in medullary thyroid carcinomas.
Reubi JC; Chayvialle JA; Franc B; Cohen R; Calmettes C; Modigliani E
Lab Invest; 1991 Apr; 64(4):567-73. PubMed ID: 1673164
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas.
Robben JH; Visser-Wisselaar HA; Rutteman GR; van Rijk PP; van Dongen AJ; Voorhout G; van den Ingh TS; Hofland LJ; Lamberts SW
J Nucl Med; 1997 Jul; 38(7):1036-42. PubMed ID: 9225787
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J
J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
[TBL] [Abstract][Full Text] [Related]
16. High incidence of somatostatin receptors in human meningiomas: biochemical characterization.
Reubi JC; Maurer R; Klijn JG; Stefanko SZ; Foekens JA; Blaauw G; Blankenstein MA; Lamberts SW
J Clin Endocrinol Metab; 1986 Aug; 63(2):433-8. PubMed ID: 3013920
[TBL] [Abstract][Full Text] [Related]
17. Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas.
Reubi JC; Horisberger U; Essed CE; Jeekel J; Klijn JG; Lamberts SW
Gastroenterology; 1988 Sep; 95(3):760-3. PubMed ID: 2899530
[TBL] [Abstract][Full Text] [Related]
18. Distinct topographical localisation of two somatostatin receptor subpopulations in the human cortex.
Reubi JC; Probst A; Cortés R; Palacios JM
Brain Res; 1987 Mar; 406(1-2):391-6. PubMed ID: 2882820
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of somatostatin receptors in rat cerebellar nuclei.
Bucharles C; Vaudry H; Leroux P
Eur J Pharmacol; 1994 Dec; 271(1):79-86. PubMed ID: 7698215
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification.
Reubi JC; Waser B; Laissue JA; Gebbers JO
Cancer Res; 1996 Apr; 56(8):1922-31. PubMed ID: 8620515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]